newheader.jpg

Search CHI's Network

 

Sanofi-Aventis is Split Over Possible Acquisition of Bristol-Myers

March 27, 2007--According to a report in the Times, Sanofi-Aventis’ chairman Jean-Francois Dehecq is in favor of a deal to acquire Bristol-Myers Squibb, while Sanofi’s chief executive Gerard Le Fur emphasizes the need for the company to focus on its internal research and development. Reuters

 

foot.jpg


Cambridge Healthtech Institute| Beyond Genome | Bio-IT World | Biomarker World Congress | Digital Healthcare & Productivity |
 Discovery On Target | Bio-IT World Conference & Expo  | Insight Pharma Reports | Molecular Medicine Tri-Conference | PEGS
PepTalk
| Pharma WeekWorld Pharmaceutical Congress

Your  Life Science Network

Cambridge Healthtech Institute  |  250 First Avenue  |  Suite 300   |   Needham,  MA  02494
Phone: 781-972-5400  |   Fax: 781-972-5425
chi@healthtech.com